186 related articles for article (PubMed ID: 30153119)
1. Visual Field Mean Deviation at Diagnosis of Idiopathic Intracranial Hypertension Predicts Visual Outcome.
Mikkilineni S; Trobe JD; Cornblath WT; De Lott L
J Neuroophthalmol; 2019 Jun; 39(2):186-190. PubMed ID: 30153119
[TBL] [Abstract][Full Text] [Related]
2. Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension.
Stiebel-Kalish H; Kalish Y; Lusky M; Gaton DD; Ehrlich R; Shuper A
Am J Ophthalmol; 2006 Aug; 142(2):279-83. PubMed ID: 16876509
[TBL] [Abstract][Full Text] [Related]
3. Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial.
Cello KE; Keltner JL; Johnson CA; Wall M;
J Neuroophthalmol; 2016 Mar; 36(1):6-12. PubMed ID: 26618282
[TBL] [Abstract][Full Text] [Related]
4. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ
JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514
[TBL] [Abstract][Full Text] [Related]
5. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension.
Gospe SM; Bhatti MT; El-Dairi MA
Br J Ophthalmol; 2016 Apr; 100(4):505-9. PubMed ID: 26269534
[TBL] [Abstract][Full Text] [Related]
6. Threshold Static Automated Perimetry of the Full Visual Field in Idiopathic Intracranial Hypertension.
Wall M; Subramani A; Chong LX; Galindo R; Turpin A; Kardon RH; Thurtell MJ; Bailey JA; Marin-Franch I
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1898-1905. PubMed ID: 31042797
[TBL] [Abstract][Full Text] [Related]
7. Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).
Wall M; Johnson CA; Cello KE; Zamba KD; McDermott MP; Keltner JL;
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):805-12. PubMed ID: 26934136
[TBL] [Abstract][Full Text] [Related]
8. Impact of Pregnancy on Papilledema and Vision Loss in Idiopathic Intracranial Hypertension Patients: A Chart Review and Case Series of 13 Patients.
Lambert-Cheatham NA; Nagia L; Pasmanter NR; Pellizzari R; Lee B; Miller NJ; Kaufman DI
J Neuroophthalmol; 2024 Jun; 44(2):206-211. PubMed ID: 37540562
[TBL] [Abstract][Full Text] [Related]
9. Ventriculoperitoneal shunt as a treatment of visual loss in idiopathic intracranial hypertension.
Huang LC; Winter TW; Herro AM; Rosa PR; Schiffman JC; Pasol J; Trombly RS; Tawfik M; Lam BL
J Neuroophthalmol; 2014 Sep; 34(3):223-8. PubMed ID: 24637911
[TBL] [Abstract][Full Text] [Related]
10. Superonasal Transconjunctival Optic Nerve Sheath Decompression: A Simplified Technique for Safe and Efficient Decompression.
Melson AT; Warmath JD; Moreau A; Farris BK
J Neuroophthalmol; 2021 Mar; 41(1):e16-e21. PubMed ID: 32141981
[TBL] [Abstract][Full Text] [Related]
11. Weight reduction for a better visual outcome in idiopathic intracranial hypertension.
Koc F; Isik MR; Sefi-Yurdakul N
Arq Bras Oftalmol; 2018; 81(1):18-23. PubMed ID: 29538589
[TBL] [Abstract][Full Text] [Related]
12. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.
Wall M; Thurtell MJ;
Br J Ophthalmol; 2017 Sep; 101(9):1256-1260. PubMed ID: 28130349
[TBL] [Abstract][Full Text] [Related]
13. Optic nerve appearance as a predictor of visual outcome in patients with idiopathic intracranial hypertension.
Micieli JA; Bruce BB; Vasseneix C; Blanch RJ; Berezovsky DE; Peragallo JH; Newman NJ; Biousse V
Br J Ophthalmol; 2019 Oct; 103(10):1429-1435. PubMed ID: 30530819
[TBL] [Abstract][Full Text] [Related]
14. Effect of Shunting on Visual Outcomes and Headache in Patients with Idiopathic Intracranial Hypertension.
Daou BJ; Sweid A; Weinberg JH; Starke RM; Sergott RC; Doermann AS; Hauge J; Zanaty M; Chalouhi N; Gooch R; Herial N; Zarzour H; Jabbour P; Rosenwasser RH; Tjoumakaris S
World Neurosurg; 2020 Oct; 142():e73-e80. PubMed ID: 32474095
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic Intracranial Hypertension in a pubertal paediatric Indian patient.
Aggarwal A; Kaur P; Chhabra K; Singh K; Goyal P
Nepal J Ophthalmol; 2017 Jan; 9(18):74-78. PubMed ID: 29022960
[TBL] [Abstract][Full Text] [Related]
16. Functional visual loss in idiopathic intracranial hypertension.
Ney JJ; Volpe NJ; Liu GT; Balcer LJ; Moster ML; Galetta SL
Ophthalmology; 2009 Sep; 116(9):1808-1813.e1. PubMed ID: 19643491
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function.
Wall M; White WN
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):134-42. PubMed ID: 9430554
[TBL] [Abstract][Full Text] [Related]
18. Long-term visual outcome in a Danish population of patients with idiopathic intracranial hypertension.
Hatem CF; Yri HM; Sørensen AL; Wegener M; Jensen RH; Hamann S
Acta Ophthalmol; 2018 Nov; 96(7):719-723. PubMed ID: 29405582
[TBL] [Abstract][Full Text] [Related]
19. Can Lumbar Puncture Be Safely Deferred in Patients With Mild Presumed Idiopathic Intracranial Hypertension?
Vosoughi AR; Margolin EA; Micieli JA
J Neuroophthalmol; 2022 Dec; 42(4):505-508. PubMed ID: 34860748
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics of Idiopathic Intracranial Hypertension in Patients Over 50 Years of Age: A multicenter clinical cohort study.
Downie PA; Chen JJ; Bhatti MT; Melson AT; Van Stavern GP; McClelland CM; Lindgren BR; Sharieff JA; Lee MS
Am J Ophthalmol; 2021 Apr; 224():96-101. PubMed ID: 33253662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
